05:09 PM EDT, 05/13/2025 (MT Newswires) -- Vaxart ( VXRT ) reported a Q1 net loss late Tuesday of $0.07 per diluted share, narrowing from the loss of $0.14 a year earlier.

Two analysts polled by FactSet expected a loss of $0.07.

Revenue in the three months ended March 31 rose to $20.9 million from $2.18 million a year earlier.

The company had cash, cash equivalents and investments of $41.9 million as of March 31 with a cash runway expected into Q1 2026.

Vaxart ( VXRT ) appointed Jeroen Grasman as chief financial officer, effective May 19. He succeeds Phillip Lee, who resigned for personal reasons, the company said.

Grasman most recently was CFO at AltruBio.

Vaxart ( VXRT ) shares rose 5.9% in after-hours trading.